A2B5 Surface ganglioside binding distinguishes between two GFAP-positive clones from a human glioma-derived cell line
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 118 (1) , 52-56
- https://doi.org/10.1016/0304-3940(90)90247-7
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Induction of the ganglioside marker A2B5 on cultured cerebellar neural cells by growth factorsNeuroscience Letters, 1989
- Development of macroglial cells in rat cerebellum. I. Use of antibodies to follow earlyin vivo development and migration of oligodendrocytesJournal of Neurocytology, 1988
- ANTIGENIC EXPRESSION BY CELLS DERIVED FROM HUMAN GLIOMAS DOES NOT CORRELATE WITH MORPHOLOGICAL CLASSIFICATIONNeuropathology and Applied Neurobiology, 1987
- Heterogeneity of a cultured neoplastic glial lineJournal of the Neurological Sciences, 1986
- Binding of momoclonal antibody A2B5 to gangliosidesBiochemical and Biophysical Research Communications, 1983
- The monoclonal antibody A2B5 is specific to ganglioside GQ1cBrain Research, 1983
- A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture mediumNature, 1983
- Expression of glial fibrillary acidic protein, actin, fibronectin and factor VIII antigen in human astrocytomasPathology, 1983
- Biosynthesis and Function of GangliosidesScience, 1976
- An acidic protein isolated from fibrous astrocytesBrain Research, 1971